آلمورکسانت (Persian Wikipedia)

Analysis of information sources in references of the Wikipedia article "آلمورکسانت" in Persian language version.

refsWebsite

Global rank Persian rank

4^th place

5^th place

2^nd place

11^th place

52^nd place

6^th place

9^th place

low place

1^st place

archive.org

Hoever, P; de Haas, S; Winkler, J; Schoemaker, R C; Chiossi, E; van Gerven, J; Dingemanse, J (May 2010). "Orexin Receptor Antagonism, a New Sleep-Promoting Paradigm: An Ascending Single-Dose Study With Almorexant". Clinical Pharmacology & Therapeutics. 87 (5): 593–600. doi:10.1038/clpt.2010.19. PMID 20376002. S2CID 37675356.

Andrews SP, Aves SJ, Christopher JA, Nonoo R (2016). "Orexin Receptor Antagonists: Historical Perspectives and Future Opportunities". Curr Top Med Chem. 16 (29): 3438–3469. doi:10.2174/1568026616666150929111607. PMID 26416477.
Hoever, P; de Haas, S; Winkler, J; Schoemaker, R C; Chiossi, E; van Gerven, J; Dingemanse, J (May 2010). "Orexin Receptor Antagonism, a New Sleep-Promoting Paradigm: An Ascending Single-Dose Study With Almorexant". Clinical Pharmacology & Therapeutics. 87 (5): 593–600. doi:10.1038/clpt.2010.19. PMID 20376002. S2CID 37675356.
Hoch, Matthias; Gorsel, Helene van; Gerven, Joop van; Dingemanse, Jasper (2014). "Entry-into-humans study with ACT-462206, a novel dual orexin receptor antagonist, comparing its pharmacodynamics with almorexant". The Journal of Clinical Pharmacology. 54 (9): 979–986. doi:10.1002/jcph.297. PMID 24691844. S2CID 40714628.
Jacobson LH, Hoyer D, de Lecea L (January 2022). "Hypocretins (orexins): The ultimate translational neuropeptides". J Intern Med. 291 (5): 533–556. doi:10.1111/joim.13406. PMID 35043499. S2CID 248119793.

Andrews SP, Aves SJ, Christopher JA, Nonoo R (2016). "Orexin Receptor Antagonists: Historical Perspectives and Future Opportunities". Curr Top Med Chem. 16 (29): 3438–3469. doi:10.2174/1568026616666150929111607. PMID 26416477.
Hoever, P; de Haas, S; Winkler, J; Schoemaker, R C; Chiossi, E; van Gerven, J; Dingemanse, J (May 2010). "Orexin Receptor Antagonism, a New Sleep-Promoting Paradigm: An Ascending Single-Dose Study With Almorexant". Clinical Pharmacology & Therapeutics. 87 (5): 593–600. doi:10.1038/clpt.2010.19. PMID 20376002. S2CID 37675356.
Neubauer DN (January 2010). "Almorexant, a dual orexin receptor antagonist for the treatment of insomnia". Current Opinion in Investigational Drugs. London, England. 11 (1): 101–10. PMID 20047164.
Hoch, Matthias; Gorsel, Helene van; Gerven, Joop van; Dingemanse, Jasper (2014). "Entry-into-humans study with ACT-462206, a novel dual orexin receptor antagonist, comparing its pharmacodynamics with almorexant". The Journal of Clinical Pharmacology. 54 (9): 979–986. doi:10.1002/jcph.297. PMID 24691844. S2CID 40714628.
Jacobson LH, Hoyer D, de Lecea L (January 2022). "Hypocretins (orexins): The ultimate translational neuropeptides". J Intern Med. 291 (5): 533–556. doi:10.1111/joim.13406. PMID 35043499. S2CID 248119793.

Hoever, P; de Haas, S; Winkler, J; Schoemaker, R C; Chiossi, E; van Gerven, J; Dingemanse, J (May 2010). "Orexin Receptor Antagonism, a New Sleep-Promoting Paradigm: An Ascending Single-Dose Study With Almorexant". Clinical Pharmacology & Therapeutics. 87 (5): 593–600. doi:10.1038/clpt.2010.19. PMID 20376002. S2CID 37675356.
Hoch, Matthias; Gorsel, Helene van; Gerven, Joop van; Dingemanse, Jasper (2014). "Entry-into-humans study with ACT-462206, a novel dual orexin receptor antagonist, comparing its pharmacodynamics with almorexant". The Journal of Clinical Pharmacology. 54 (9): 979–986. doi:10.1002/jcph.297. PMID 24691844. S2CID 40714628.
Jacobson LH, Hoyer D, de Lecea L (January 2022). "Hypocretins (orexins): The ultimate translational neuropeptides". J Intern Med. 291 (5): 533–556. doi:10.1111/joim.13406. PMID 35043499. S2CID 248119793.